Page last updated: 2024-10-29

iopromide and Minimal Disease, Residual

iopromide has been researched along with Minimal Disease, Residual in 2 studies

iopromide: structure given in first source
iopromide : A dicarboxylic acid diamide that consists of N-methylisophthalamide bearing three iodo substituents at positions 2, 4 and 6, a methoxyacetyl substituent at position 5 and two 2,3-dihydroxypropyl groups attached to the amide nitrogens. A water soluble x-ray contrast agent for intravascular administration.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Vandenbroucke, F1
Vandemeulebroucke, J1
Ilsen, B1
Verdries, D1
Belsack, D1
Everaert, H1
Buls, N1
Ros, PR1
de Mey, J1
Spira, D1
Vogel, W1
Sökler, M1
Löffler, S1
Sauter, A1
Schulze, M1
Horger, M1

Other Studies

2 other studies available for iopromide and Minimal Disease, Residual

ArticleYear
Predictive value of pattern classification 24 hours after radiofrequency ablation of liver metastases on CT and positron emission tomography/CT.
    Journal of vascular and interventional radiology : JVIR, 2014, Volume: 25, Issue:8

    Topics: Catheter Ablation; Contrast Media; Disease Progression; Fluorodeoxyglucose F18; Humans; Iohexol; Liv

2014
Size and attenuation CT (SACT) of residual masses in patients with follicular non-Hodgkin lymphoma: more than a status quo?
    European journal of radiology, 2012, Volume: 81, Issue:7

    Topics: Adult; Aged; Contrast Media; Female; Humans; Iohexol; Lymphoma, Follicular; Lymphoma, Non-Hodgkin; M

2012